Here's what to expect: 

• 18+ TGF-β expert speakers
• 67% Brand New Speaking Companies such as AbbVie, Pfizer, Oncotelic Therapeutics, & Amgen
• 35% of Content Exploring TGF-β Beyond Oncology
• 6+ Hours of Interactive Networking
• 2 Deep Dive Workshops on Designing the Most Effective Clinical Trials for TGF-β Targeted
  Therapies Toward Clinical Efficacy, and Avoiding the Pitfalls in Targeting TGF-β to Achieve Better Specificity,
  Reduced Toxicity & More Effective Treatments